Rezultati - Katelyn Brown

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program

    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program od Ildiko Lingvay, Ofri Mosenzon, Katelyn Brown, Xuewei Cui, Ciara O’Neill, Laura Fernández Landó, Hiren Patel

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: <scp>H</scp>igher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide

    Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: <scp>H</scp>igher adherence and persistence with dulaglutide co... od Carlos Alatorre, Laura Fernández Landó, Maria Yu, Katelyn Brown, Leslie Montejano, Paul Juneau, Reema Mody, Ralph Swindle

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes od Juan P. Frías, Melanie J. Davies, Julio Rosenstock, Federico C. Pérez Manghi, Laura Fernández Landó, Brandon K. Bergman, Bing Liu, Xuewei Cui, Katelyn Brown

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: